Oakmont Corp’s Amgen AMGN Stock Holding History

Oakmont Corp’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$69.7K	Hold	198	–	–	0.01%	25
2025 Q4	$64.8K	Hold	198	–	–	0.01%	25
2025 Q3	$55.9K	Hold	198	–	–	0.01%	26
2025 Q2	$55.3K	Hold	198	–	–	0.01%	25
2025 Q1	$61.7K	Hold	198	–	–	0.01%	25
2024 Q4	$51.6K	Hold	198	–	–	0.01%	23
2024 Q3	$63.2K	Hold	198	–	–	0.01%	26
2024 Q2	$61.9K	Hold	198	–	–	0.01%	25
2024 Q1	$56.3K	Hold	198	–	–	0.01%	27
2023 Q4	$57K	Sell	198 -19	-9%	-$5.18K	0.02%	26
2023 Q3	$58.3K	Hold	217	–	–	0.02%	29
2023 Q2	$48.2K	Sell	217 -54	-20%	-$12.5K	0.01%	30
2023 Q1	$65.5K	Hold	271	–	–	0.01%	29
2022 Q4	$71K	Hold	271	–	–	0.01%	26
2022 Q3	$61K	Hold	271	–	–	0.01%	26
2022 Q2	$66K	Sell	271 -69	-20%	-$16.9K	0.01%	28
2022 Q1	$82K	Buy	+340	New	+$78.1K	0.01%	29

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Oakmont Corp's AMGN Position: Q1 2026 in Review

Oakmont Corp held its Amgen (AMGN) position steady in Q1 2026 at 198 shares worth $69.7K. The position accounts for 0.01% of the portfolio, ranked #25.

Oakmont Corp first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. The position peaked at $82K in Q1 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Oakmont Corp held 198 shares of Amgen worth $69.7K as of Q1 2026.
Oakmont Corp left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.01% of Oakmont Corp's portfolio in Q1 2026, its #25 holding.
Oakmont Corp first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
Oakmont Corp's Amgen position peaked at $82K in Q1 2022.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Oakmont Corp's 13F filing for Q1 2026, filed 12 May 2026.